MSGS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Madison Square Garden Sports Corp (MSGS) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock has positive long-term catalysts, including potential spin-offs of its major teams, strong analyst ratings, and a bullish moving average trend. Despite short-term financial challenges, the company's assets and strategic moves suggest growth potential over time.
The stock's moving averages are bullish (SMA_5 > SMA_20 > SMA_200), indicating an upward trend. However, the MACD histogram is negative (-0.378), showing bearish momentum, and RSI is neutral at 50.715. Key support is at 312.527, and resistance is at 331.703.
Analysts have raised price targets significantly, with JPMorgan suggesting a high intention to execute a spin-off of the Knicks and Rangers.
Citi highlights the potential for a minority stake sale to close the valuation gap.
The stock has a 12.64% chance of increasing in the next month based on historical patterns.
Financial performance in Q1 2026 shows declining revenue (-25.99% YoY) and gross margin (-6.20% YoY), though net income and EPS have improved.
Lack of recent news or significant hedge fund/insider activity.
Wolfe Research downgraded the stock, citing minimal catalysts for short-term upside.
In Q1 2026, revenue dropped significantly (-25.99% YoY), but net income improved by 16.74% YoY, and EPS increased by 19.35% YoY. Gross margin declined to 80.28% (-6.20% YoY), reflecting operational challenges.
Analysts are generally positive on MSGS, with multiple firms raising price targets recently. JPMorgan raised its target to $400, citing a potential spin-off, while Citi and Susquehanna also raised targets to $337 and $356, respectively. Wolfe Research downgraded the stock, citing limited short-term catalysts.
